Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 398 entries
Sorted by: Best Match Show Resources per page
Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer.

OncoTargets and therapy

Ono M, Ito T, Kanai T, Murayama K, Koyama H, Maeno K, Mochizuki Y, Iesato A, Hanamura T, Okada T, Watanabe T, Ito K.
PMID: 24124381
Onco Targets Ther. 2013 Oct 07;6:1393-8. doi: 10.2147/OTT.S51164. eCollection 2013.

Bevacizumab when combined with chemotherapy exerts significant activity against many solid tumors through tumor angiogenesis inhibition; however, it can induce severe side effects. We report the rare case of a 27-year-old premenopausal woman with locally advanced breast cancer that...

Cite
Ono M, Ito T, Kanai T, et al. Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer. Onco Targets Ther. 2013;6:1393-8doi: 10.2147/OTT.S51164.
Ono, M., Ito, T., Kanai, T., Murayama, K., Koyama, H., Maeno, K., Mochizuki, Y., Iesato, A., Hanamura, T., Okada, T., Watanabe, T., & Ito, K. (2013). Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer. OncoTargets and therapy, 61393-8. https://doi.org/10.2147/OTT.S51164
Ono, Mayu, et al. "Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer." OncoTargets and therapy vol. 6 (2013): 1393-8. doi: https://doi.org/10.2147/OTT.S51164
Ono M, Ito T, Kanai T, Murayama K, Koyama H, Maeno K, Mochizuki Y, Iesato A, Hanamura T, Okada T, Watanabe T, Ito K. Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer. Onco Targets Ther. 2013 Oct 07;6:1393-8. doi: 10.2147/OTT.S51164. eCollection 2013. PMID: 24124381; PMCID: PMC3794845.
Copy Download .nbib Format: NLM
Oral cenesthopathy.

BioPsychoSocial medicine

Umezaki Y, Miura A, Watanabe M, Takenoshita M, Uezato A, Toriihara A, Nishikawa T, Toyofuku A.
PMID: 27293481
Biopsychosoc Med. 2016 Jun 10;10:20. doi: 10.1186/s13030-016-0071-7. eCollection 2016.

Cenesthopathy is characterized by abnormal and strange bodily sensations and is classified as a 'delusional disorder, somatic type' or 'somatoform disorder' according to the DSM 5. The oral cavity is one of the frequent sites of cenesthopathy, thus the...

Cite
Umezaki Y, Miura A, Watanabe M, et al. Oral cenesthopathy. Biopsychosoc Med. 2016;10:20doi: 10.1186/s13030-016-0071-7.
Umezaki, Y., Miura, A., Watanabe, M., Takenoshita, M., Uezato, A., Toriihara, A., Nishikawa, T., & Toyofuku, A. (2016). Oral cenesthopathy. BioPsychoSocial medicine, 1020. https://doi.org/10.1186/s13030-016-0071-7
Umezaki, Yojiro, et al. "Oral cenesthopathy." BioPsychoSocial medicine vol. 10 (2016): 20. doi: https://doi.org/10.1186/s13030-016-0071-7
Umezaki Y, Miura A, Watanabe M, Takenoshita M, Uezato A, Toriihara A, Nishikawa T, Toyofuku A. Oral cenesthopathy. Biopsychosoc Med. 2016 Jun 10;10:20. doi: 10.1186/s13030-016-0071-7. eCollection 2016. PMID: 27293481; PMCID: PMC4903001.
Copy Download .nbib Format: NLM
The future of metabolomics in ELIXIR.

F1000Research

van Rijswijk M, Beirnaert C, Caron C, Cascante M, Dominguez V, Dunn WB, Ebbels TMD, Giacomoni F, Gonzalez-Beltran A, Hankemeier T, Haug K, Izquierdo-Garcia JL, Jimenez RC, Jourdan F, Kale N, Klapa MI, Kohlbacher O, Koort K, Kultima K, Le Corguillé G, Moreno P, Moschonas NK, Neumann S, O'Donovan C, Reczko M, Rocca-Serra P, Rosato A, Salek RM, Sansone SA, Satagopam V, Schober D, Shimmo R, Spicer RA, Spjuth O, Thévenot EA, Viant MR, Weber RJM, Willighagen EL, Zanetti G, Steinbeck C.
PMID: 29043062
F1000Res. 2017 Sep 06;6. doi: 10.12688/f1000research.12342.2. eCollection 2017.

Metabolomics, the youngest of the major omics technologies, is supported by an active community of researchers and infrastructure developers across Europe. To coordinate and focus efforts around infrastructure building for metabolomics within Europe, a workshop on the "Future of...

Cite
van Rijswijk M, Beirnaert C, Caron C, et al. The future of metabolomics in ELIXIR. F1000Res. 2017;6doi: 10.12688/f1000research.12342.2.
van Rijswijk, M., Beirnaert, C., Caron, C., Cascante, M., Dominguez, V., Dunn, W. B., Ebbels, T. M. D., Giacomoni, F., Gonzalez-Beltran, A., Hankemeier, T., Haug, K., Izquierdo-Garcia, J. L., Jimenez, R. C., Jourdan, F., Kale, N., Klapa, M. I., Kohlbacher, O., Koort, K., Kultima, K., Le Corguillé, G., Moreno, P., Moschonas, N. K., Neumann, S., O'Donovan, C., Reczko, M., Rocca-Serra, P., Rosato, A., Salek, R. M., Sansone, S. A., Satagopam, V., Schober, D., Shimmo, R., Spicer, R. A., Spjuth, O., Thévenot, E. A., Viant, M. R., Weber, R. J. M., Willighagen, E. L., Zanetti, G., & Steinbeck, C. (2017). The future of metabolomics in ELIXIR. F1000Research, 6. https://doi.org/10.12688/f1000research.12342.2
van Rijswijk, Merlijn, et al. "The future of metabolomics in ELIXIR." F1000Research vol. 6 (2017). doi: https://doi.org/10.12688/f1000research.12342.2
van Rijswijk M, Beirnaert C, Caron C, Cascante M, Dominguez V, Dunn WB, Ebbels TMD, Giacomoni F, Gonzalez-Beltran A, Hankemeier T, Haug K, Izquierdo-Garcia JL, Jimenez RC, Jourdan F, Kale N, Klapa MI, Kohlbacher O, Koort K, Kultima K, Le Corguillé G, Moreno P, Moschonas NK, Neumann S, O'Donovan C, Reczko M, Rocca-Serra P, Rosato A, Salek RM, Sansone SA, Satagopam V, Schober D, Shimmo R, Spicer RA, Spjuth O, Thévenot EA, Viant MR, Weber RJM, Willighagen EL, Zanetti G, Steinbeck C. The future of metabolomics in ELIXIR. F1000Res. 2017 Sep 06;6. doi: 10.12688/f1000research.12342.2. eCollection 2017. PMID: 29043062; PMCID: PMC5627583.
Copy Download .nbib Format: NLM
Tumor heterogeneity on (18)F-FDG-PET/CT for response monitoring in non-small cell lung cancer treated with erlotinib.

Journal of thoracic disease

van Gool MH, Aukema TS, Sinaasappel M, Valdés Olmos RA, Klomp HM.
PMID: 27076970
J Thorac Dis. 2016 Mar;8(3):E200-3. doi: 10.21037/jtd.2016.02.10.

Response monitoring using fluorodeoxyglucose positron emission tomography acquired together with low dose computed tomography (FDG-PET/CT) textural features has potential in targeted treatment with erlotinib in non-small cell lung cancer (NSCLC) patients. Patients with substantial decrease of metabolic activity during...

Cite
van Gool MH, Aukema TS, Sinaasappel M, et al. Tumor heterogeneity on (18)F-FDG-PET/CT for response monitoring in non-small cell lung cancer treated with erlotinib. J Thorac Dis. 2016;8(3):E200-3doi: 10.21037/jtd.2016.02.10.
van Gool, M. H., Aukema, T. S., Sinaasappel, M., Valdés Olmos, R. A., & Klomp, H. M. (2016). Tumor heterogeneity on (18)F-FDG-PET/CT for response monitoring in non-small cell lung cancer treated with erlotinib. Journal of thoracic disease, 8(3), E200-3. https://doi.org/10.21037/jtd.2016.02.10
van Gool, Matthijs H, et al. "Tumor heterogeneity on (18)F-FDG-PET/CT for response monitoring in non-small cell lung cancer treated with erlotinib." Journal of thoracic disease vol. 8,3 (2016): E200-3. doi: https://doi.org/10.21037/jtd.2016.02.10
van Gool MH, Aukema TS, Sinaasappel M, Valdés Olmos RA, Klomp HM. Tumor heterogeneity on (18)F-FDG-PET/CT for response monitoring in non-small cell lung cancer treated with erlotinib. J Thorac Dis. 2016 Mar;8(3):E200-3. doi: 10.21037/jtd.2016.02.10. PMID: 27076970; PMCID: PMC4805797.
Copy Download .nbib Format: NLM
Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review.

OncoTargets and therapy

Oba T, Ono M, Iesato A, Hanamura T, Watanabe T, Ito T, Kanai T, Maeno K, Ito K, Tateishi A, Yoshizawa A, Takayama F.
PMID: 27051299
Onco Targets Ther. 2016 Mar 18;9:1641-6. doi: 10.2147/OTT.S88726. eCollection 2016.

Lipid-rich carcinoma (LRC) of the breast is a rare breast cancer variant that accounts for

Cite
Oba T, Ono M, Iesato A, et al. Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review. Onco Targets Ther. 2016;9:1641-6doi: 10.2147/OTT.S88726.
Oba, T., Ono, M., Iesato, A., Hanamura, T., Watanabe, T., Ito, T., Kanai, T., Maeno, K., Ito, K., Tateishi, A., Yoshizawa, A., & Takayama, F. (2016). Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review. OncoTargets and therapy, 91641-6. https://doi.org/10.2147/OTT.S88726
Oba, Takaaki, et al. "Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review." OncoTargets and therapy vol. 9 (2016): 1641-6. doi: https://doi.org/10.2147/OTT.S88726
Oba T, Ono M, Iesato A, Hanamura T, Watanabe T, Ito T, Kanai T, Maeno K, Ito K, Tateishi A, Yoshizawa A, Takayama F. Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review. Onco Targets Ther. 2016 Mar 18;9:1641-6. doi: 10.2147/OTT.S88726. eCollection 2016. PMID: 27051299; PMCID: PMC4807953.
Copy Download .nbib Format: NLM
Renal function estimated from serum creatinine is overestimated in patients with rheumatoid arthritis because of their muscle atrophy.

Modern rheumatology

Moriguchi M, Terai C, Koseki Y, Uesato M, Kamatani N.
PMID: 24383635
Mod Rheumatol. 2000 Dec;10(4):230-4. doi: 10.3109/s101650070008.

Abstract We evaluated the reliability of serum creatinine concentration (Scr) to estimate renal function in patients with rheumatoid arthritis (RA). To quantify muscle volume (study 1) the lean body mass (LBM) in 25 women RA patients and 10 controls...

Cite
Moriguchi M, Terai C, Koseki Y, et al. Renal function estimated from serum creatinine is overestimated in patients with rheumatoid arthritis because of their muscle atrophy. Mod Rheumatol. 2000;10(4):230-4doi: 10.3109/s101650070008.
Moriguchi, M., Terai, C., Koseki, Y., Uesato, M., & Kamatani, N. (2000). Renal function estimated from serum creatinine is overestimated in patients with rheumatoid arthritis because of their muscle atrophy. Modern rheumatology, 10(4), 230-4. https://doi.org/10.3109/s101650070008
Moriguchi, M, et al. "Renal function estimated from serum creatinine is overestimated in patients with rheumatoid arthritis because of their muscle atrophy." Modern rheumatology vol. 10,4 (2000): 230-4. doi: https://doi.org/10.3109/s101650070008
Moriguchi M, Terai C, Koseki Y, Uesato M, Kamatani N. Renal function estimated from serum creatinine is overestimated in patients with rheumatoid arthritis because of their muscle atrophy. Mod Rheumatol. 2000 Dec;10(4):230-4. doi: 10.3109/s101650070008. PMID: 24383635.
Copy Download .nbib Format: NLM
The Da Vinci European BioBank: A Metabolomics-Driven Infrastructure.

Journal of personalized medicine

Carotenuto D, Luchinat C, Marcon G, Rosato A, Turano P.
PMID: 25913579
J Pers Med. 2015 Apr 22;5(2):107-19. doi: 10.3390/jpm5020107.

We present here the organization of the recently-constituted da Vinci European BioBank (daVEB, https://www.davincieuropeanbiobank.org/it). The biobank was created as an infrastructure to support the activities of the Fiorgen Foundation (http://www.fiorgen.net/), a nonprofit organization that promotes research in the field...

Cite
Carotenuto D, Luchinat C, Marcon G, et al. The Da Vinci European BioBank: A Metabolomics-Driven Infrastructure. J Pers Med. 2015;5(2):107-19doi: 10.3390/jpm5020107.
Carotenuto, D., Luchinat, C., Marcon, G., Rosato, A., & Turano, P. (2015). The Da Vinci European BioBank: A Metabolomics-Driven Infrastructure. Journal of personalized medicine, 5(2), 107-19. https://doi.org/10.3390/jpm5020107
Carotenuto, Dario, et al. "The Da Vinci European BioBank: A Metabolomics-Driven Infrastructure." Journal of personalized medicine vol. 5,2 (2015): 107-19. doi: https://doi.org/10.3390/jpm5020107
Carotenuto D, Luchinat C, Marcon G, Rosato A, Turano P. The Da Vinci European BioBank: A Metabolomics-Driven Infrastructure. J Pers Med. 2015 Apr 22;5(2):107-19. doi: 10.3390/jpm5020107. PMID: 25913579; PMCID: PMC4493490.
Copy Download .nbib Format: NLM
Does Accidental Overcorrection of Symptomatic Hyponatremia in Chronic Heart Failure Require Specific Therapeutic Adjustments for Preventing Central Pontine Myelinolysis?.

Journal of clinical medicine research

De Vecchis R, Noutsias M, Ariano C, Cesaro A, Cioppa C, Giasi A, Maurea N.
PMID: 28270885
J Clin Med Res. 2017 Apr;9(4):266-272. doi: 10.14740/jocmr2933w. Epub 2017 Feb 21.

This review aims at summarizing essential aspects of epidemiology and pathophysiology of hyponatremia in chronic heart failure (CHF), to set the ground for a practical as well as evidence-based approach to treatment. As a guide through the discussion of...

Cite
De Vecchis R, Noutsias M, Ariano C, et al. Does Accidental Overcorrection of Symptomatic Hyponatremia in Chronic Heart Failure Require Specific Therapeutic Adjustments for Preventing Central Pontine Myelinolysis?. J Clin Med Res. 2017;9(4):266-272doi: 10.14740/jocmr2933w.
De Vecchis, R., Noutsias, M., Ariano, C., Cesaro, A., Cioppa, C., Giasi, A., & Maurea, N. (2017). Does Accidental Overcorrection of Symptomatic Hyponatremia in Chronic Heart Failure Require Specific Therapeutic Adjustments for Preventing Central Pontine Myelinolysis?. Journal of clinical medicine research, 9(4), 266-272. https://doi.org/10.14740/jocmr2933w
De Vecchis, Renato, et al. "Does Accidental Overcorrection of Symptomatic Hyponatremia in Chronic Heart Failure Require Specific Therapeutic Adjustments for Preventing Central Pontine Myelinolysis?." Journal of clinical medicine research vol. 9,4 (2017): 266-272. doi: https://doi.org/10.14740/jocmr2933w
De Vecchis R, Noutsias M, Ariano C, Cesaro A, Cioppa C, Giasi A, Maurea N. Does Accidental Overcorrection of Symptomatic Hyponatremia in Chronic Heart Failure Require Specific Therapeutic Adjustments for Preventing Central Pontine Myelinolysis?. J Clin Med Res. 2017 Apr;9(4):266-272. doi: 10.14740/jocmr2933w. Epub 2017 Feb 21. PMID: 28270885; PMCID: PMC5330768.
Copy Download .nbib Format: NLM
Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4.

Frontiers in immunology

Muraro E, Merlo A, Martorelli D, Cangemi M, Dalla Santa S, Dolcetti R, Rosato A.
PMID: 28289418
Front Immunol. 2017 Feb 27;8:197. doi: 10.3389/fimmu.2017.00197. eCollection 2017.

CD4

Cite
Muraro E, Merlo A, Martorelli D, et al. Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4. Front Immunol. 2017;8:197doi: 10.3389/fimmu.2017.00197.
Muraro, E., Merlo, A., Martorelli, D., Cangemi, M., Dalla Santa, S., Dolcetti, R., & Rosato, A. (2017). Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4. Frontiers in immunology, 8197. https://doi.org/10.3389/fimmu.2017.00197
Muraro, Elena, et al. "Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4." Frontiers in immunology vol. 8 (2017): 197. doi: https://doi.org/10.3389/fimmu.2017.00197
Muraro E, Merlo A, Martorelli D, Cangemi M, Dalla Santa S, Dolcetti R, Rosato A. Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4. Front Immunol. 2017 Feb 27;8:197. doi: 10.3389/fimmu.2017.00197. eCollection 2017. PMID: 28289418; PMCID: PMC5327441.
Copy Download .nbib Format: NLM
Coevolutionary particle swarm optimization using Gaussian distribution for solving constrained optimization problems.

IEEE transactions on systems, man, and cybernetics. Part B, Cybernetics : a publication of the IEEE Systems, Man, and Cybernetics Society

Krohling RA, Coelho Ldos S.
PMID: 17186816
IEEE Trans Syst Man Cybern B Cybern. 2006 Dec;36(6):1407-16. doi: 10.1109/tsmcb.2006.873185.

In this correspondence, an approach based on coevolutionary particle swarm optimization to solve constrained optimization problems formulated as min-max problems is presented. In standard or canonical particle swarm optimization (PSO), a uniform probability distribution is used to generate random...

Cite
Krohling RA, Coelho Ldos S. Coevolutionary particle swarm optimization using Gaussian distribution for solving constrained optimization problems. IEEE Trans Syst Man Cybern B Cybern. 2006;36(6):1407-16doi: 10.1109/tsmcb.2006.873185.
Krohling, R. A., & Coelho, L. d. o. s. . S. (2006). Coevolutionary particle swarm optimization using Gaussian distribution for solving constrained optimization problems. IEEE transactions on systems, man, and cybernetics. Part B, Cybernetics : a publication of the IEEE Systems, Man, and Cybernetics Society, 36(6), 1407-16. https://doi.org/10.1109/tsmcb.2006.873185
Krohling, Renato A, and Coelho, Leandro dos Santos. "Coevolutionary particle swarm optimization using Gaussian distribution for solving constrained optimization problems." IEEE transactions on systems, man, and cybernetics. Part B, Cybernetics : a publication of the IEEE Systems, Man, and Cybernetics Society vol. 36,6 (2006): 1407-16. doi: https://doi.org/10.1109/tsmcb.2006.873185
Krohling RA, Coelho Ldos S. Coevolutionary particle swarm optimization using Gaussian distribution for solving constrained optimization problems. IEEE Trans Syst Man Cybern B Cybern. 2006 Dec;36(6):1407-16. doi: 10.1109/tsmcb.2006.873185. PMID: 17186816.
Copy Download .nbib Format: NLM
LH, FSH, PRL and ACTH cells in pituitary glands of cows with ovarian cysts.

Theriogenology

Busato A, Romagnoli S, Küpfer U, Rossi GL, Bestetti GE.
PMID: 16727723
Theriogenology. 1995 Jul 15;44(2):233-46. doi: 10.1016/0093-691x(95)00173-6.

We investigated morphometrically and densitometrically LH, FSH, PRL, and ACTH cells in pituitary glands in cows with follicular cysts and normal animals. Three groups were considered: cows in diestrus, cows in periestrus and cows with follicular cysts. The periestrous...

Cite
Busato A, Romagnoli S, Küpfer U, et al. LH, FSH, PRL and ACTH cells in pituitary glands of cows with ovarian cysts. Theriogenology. 1995;44(2):233-46doi: 10.1016/0093-691x(95)00173-6.
Busato, A., Romagnoli, S., Küpfer, U., Rossi, G. L., & Bestetti, G. E. (1995). LH, FSH, PRL and ACTH cells in pituitary glands of cows with ovarian cysts. Theriogenology, 44(2), 233-46. https://doi.org/10.1016/0093-691x(95)00173-6
Busato, A, et al. "LH, FSH, PRL and ACTH cells in pituitary glands of cows with ovarian cysts." Theriogenology vol. 44,2 (1995): 233-46. doi: https://doi.org/10.1016/0093-691x(95)00173-6
Busato A, Romagnoli S, Küpfer U, Rossi GL, Bestetti GE. LH, FSH, PRL and ACTH cells in pituitary glands of cows with ovarian cysts. Theriogenology. 1995 Jul 15;44(2):233-46. doi: 10.1016/0093-691x(95)00173-6. PMID: 16727723.
Copy Download .nbib Format: NLM
Occurrence of midgut perimicrovillar membranes in paraneopteran insect orders with comments on their function and evolutionary significance.

Arthropod structure & development

Silva CP, Silva JR, Vasconcelos FF, Petretski MD, Damatta RA, Ribeiro AF, Terra WR.
PMID: 18089029
Arthropod Struct Dev. 2004 Apr;33(2):139-48. doi: 10.1016/j.asd.2003.12.002.

Hemipterans are characterized by the absence of the peritrophic membrane, an anatomical structure that envelopes the food bolus in the majority of insects. However, the microvillar membranes of many hemipteran midgut cells are not in direct contact with the...

Cite
Silva CP, Silva JR, Vasconcelos FF, et al. Occurrence of midgut perimicrovillar membranes in paraneopteran insect orders with comments on their function and evolutionary significance. Arthropod Struct Dev. 2004;33(2):139-48doi: 10.1016/j.asd.2003.12.002.
Silva, C. P., Silva, J. R., Vasconcelos, F. F., Petretski, M. D., Damatta, R. A., Ribeiro, A. F., & Terra, W. R. (2004). Occurrence of midgut perimicrovillar membranes in paraneopteran insect orders with comments on their function and evolutionary significance. Arthropod structure & development, 33(2), 139-48. https://doi.org/10.1016/j.asd.2003.12.002
Silva, Carlos P, et al. "Occurrence of midgut perimicrovillar membranes in paraneopteran insect orders with comments on their function and evolutionary significance." Arthropod structure & development vol. 33,2 (2004): 139-48. doi: https://doi.org/10.1016/j.asd.2003.12.002
Silva CP, Silva JR, Vasconcelos FF, Petretski MD, Damatta RA, Ribeiro AF, Terra WR. Occurrence of midgut perimicrovillar membranes in paraneopteran insect orders with comments on their function and evolutionary significance. Arthropod Struct Dev. 2004 Apr;33(2):139-48. doi: 10.1016/j.asd.2003.12.002. PMID: 18089029.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 398 entries